To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CMTM3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
490 supporting clones for gene CMTM3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BF436703 fibrotheoma, ovary CMTM3.a 1 to 162 1 to 162   tiling clone, Submitted on the opposite strand 162/162
(100 %)
1 diff
(99.4 %id)
AA810646 germinal center B cell CMTM3.a 30 to 472 1 to 438   tiling clone, Submitted on the opposite strand 438/438
(100 %)
11 diff
(97.5 %id)
BP291141 lung CMTM3.a 428 to 999 1 to 571   tiling clone,   571/571
(100 %)
2 diff
(99.7 %id)
CR979086 T-Lymphocytes CMTM3.b 1 to 549 1 to 549   tiling clone,   549/550
(99 %)
3 diff
(99.5 %id)
DB120630 thymus CMTM3.b 77 to 635 2 to 560   tiling clone, capped   559/559
(100 %)
1 diff
(99.9 %id)
BU621695 cell lines, Chondrosarcoma CMTM3.b 515 to 1157 660 to 19   tiling clone, AAA   642/642
(100 %)
1 diff
(99.9 %id)
CR983229 T-Lymphocytes CMTM3.c 1 to 714 1 to 714 exact tiling clone,   714/715
(99 %)
2 diff
(99.8 %id)
BM906164 ovary (pool of 3) CMTM3.d 1 to 745 67 to 826 A171S H172P K173Q T174D E175R ... tiling clone,   760/1264
(60 %)
34 diff
(97.4 %id)
DA711241   CMTM3.e 1 to 450 2 to 451   tiling clone, capped   450/450
(100 %)
2 diff
(99.6 %id)
BM146864 leukopheresis CMTM3.e 313 to 832 1 to 521       521/539
(96 %)
4 diff
(99.3 %id)
NM_181554.1   CMTM3.e 314 to 2330 1 to 2017   RefSeq, AAA   2017/2017
(100 %)
0 diff
(100 %id)
DA912934   CMTM3.e 333 to 895 2 to 564   capped   563/563
(100 %)
2 diff
(99.7 %id)
DB059777 testis CMTM3.e 333 to 656 2 to 325   capped   324/324
(100 %)
2 diff
(99.4 %id)
BM564144 brain, medulla CMTM3.e 360 to 1363 10 to 1023   tiling clone,   1014/1024
(99 %)
37 diff
(96.4 %id)
BM563711 brain, medulla CMTM3.e 377 to 1106 10 to 749 K130Q I150D F151L N152*     740/1137
(65 %)
27 diff
(97.7 %id)
CB997908 placenta, pre-eclamptic placenta CMTM3.f 1 to 691 28 to 725   tiling clone,   698/789
(88 %)
14 diff
(98.3 %id)
NM_144601.2   CMTM3.f 35 to 2157 1 to 2123 exact RefSeq, AAA   2123/2123
(100 %)
0 diff
(100 %id)
BX357502 Placenta Cot 25-normalized CMTM3.f 49 to 849 1 to 799       799/799
(100 %)
8 diff
(99.0 %id)
DA699044   CMTM3.f 61 to 476 8 to 423   capped   416/416
(100 %)
0 diff
(100 %id)
AF479813 placenta CMTM3.f 75 to 2157 1 to 2082 exact tiling clone, AAA   2082/2082
(100 %)
3 diff
(99.9 %id)
BG770255 melanotic melanoma, high MDR (cell line), skin CMTM3.f 75 to 842 1 to 760       760/760
(100 %)
14 diff
(98.2 %id)
BX398157 Placenta Cot 25-normalized CMTM3.f 77 to 1081 1 to 998 M100I M101D D102G F103L L104P ... fully sequenced,   998/998
(100 %)
21 diff
(97.9 %id)
CR597108 Placenta Cot 25-normalized CMTM3.f 162 to 1982 1 to 1821 exact     1821/1821
(100 %)
0 diff
(100 %id)
BX385943 Placenta Cot 25-normalized CMTM3.f 162 to 1034 14 to 885 Q88X L96X V134G F135V G136W ...     872/885
(98 %)
23 diff
(97.5 %id)
AL570379 placenta, Placenta Cot 25-normalized CMTM3.f 163 to 611 1 to 455       455/477
(95 %)
13 diff
(97.3 %id)
BX335807 Placenta Cot 25-normalized CMTM3.f 163 to 1080 1 to 913 P3X Q88X fully sequenced,   913/913
(100 %)
5 diff
(99.5 %id)
DB023891 testis CMTM3.f 176 to 724 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
BX335806 Placenta Cot 25-normalized CMTM3.f 1050 to 1982 932 to 1   fully sequenced,   932/932
(100 %)
16 diff
(98.3 %id)
BX398156 Placenta Cot 25-normalized CMTM3.f 1051 to 2098 1035 to 1   fully sequenced,   1035/1035
(100 %)
18 diff
(98.3 %id)
BX357501 Placenta Cot 25-normalized CMTM3.f 1127 to 1964 841 to 7       835/841
(99 %)
0 diff
(100 %id)
AK056324   CMTM3.g 1 to 2317 2 to 2318 exact tiling clone, available from FLJ,   2318/2318
(100 %)
0 diff
(100 %id)
DA704422   CMTM3.g 1 to 402 2 to 403   capped   402/402
(100 %)
0 diff
(100 %id)
DB462656 testis CMTM3.g 267 to 750 1 to 484       484/484
(100 %)
2 diff
(99.6 %id)
NM_001048251.1   CMTM3.g 267 to 2327 1 to 2061 exact RefSeq, AAA   2061/2061
(100 %)
0 diff
(100 %id)
DA560382 heart CMTM3.g 279 to 850 2 to 573   capped   572/572
(100 %)
3 diff
(99.5 %id)
BI462325 testis CMTM3.g 419 to 924 1 to 535       535/676
(79 %)
57 diff
(91.6 %id)
BM563004 duodenal adenocarcinoma, cell line, small intestine CMTM3.g 434 to 1207 1 to 786 H170P K171Q T172D E173R E174R ...     786/1051
(74 %)
33 diff
(96.9 %id)
BM563545 brain, medulla CMTM3.g 438 to 1371 17 to 967 K171P T172D E173R E174K E175K ...     951/1183
(80 %)
50 diff
(95.8 %id)
BM560395 brain, medulla CMTM3.g 443 to 1267 4 to 838 R28C W93R     835/1050
(79 %)
30 diff
(97.2 %id)
BI826251 brain, medulla CMTM3.g 444 to 1130 1 to 688 D9E P20A L45R L46A A47G ...     688/688
(100 %)
6 diff
(99.2 %id)
TI_57173332   CMTM3.g 444 to 1130 31 to 718 D9E P20A L45R L46A A47G ...     688/718
(95 %)
8 diff
(98.9 %id)
CR625182 Placenta Cot 25-normalized CMTM3.g 446 to 2145 1 to 1700 exact     1700/1700
(100 %)
0 diff
(100 %id)
BX365301 Placenta Cot 25-normalized CMTM3.g 446 to 1404 1 to 947 D5X P6X S49X S52X Y59X ...     947/1046
(90 %)
23 diff
(97.9 %id)
DA926559 small intestine CMTM3.g 446 to 833 2 to 390   capped   389/389
(100 %)
1 diff
(99.8 %id)
BQ940554 leiomyosarcoma, uterus CMTM3.g 447 to 925 1 to 482       482/1104
(43 %)
12 diff
(99.0 %id)
BM926441 pooled lung and spleen CMTM3.g 448 to 1386 11 to 958 exact     948/1158
(81 %)
30 diff
(97.5 %id)
CR976711 T-Lymphocytes CMTM3.g 448 to 671 33 to 256       224/265
(84 %)
2 diff
(99.3 %id)
CR598427 T cells (Jurkat cell line) Cot10-normalized CMTM3.g 451 to 2145 1 to 1695 exact     1695/1695
(100 %)
0 diff
(100 %id)
BX324981   CMTM3.g 451 to 1298 1 to 848 P3X D5X S49X S52X A128X ... fully sequenced,   848/848
(100 %)
4 diff
(99.6 %id)
CR615620 Neuroblastoma Cot 25-normalized CMTM3.g 452 to 2152 1 to 1701 exact     1701/1701
(100 %)
0 diff
(100 %id)
BX376202 Neuroblastoma Cot 25-normalized CMTM3.g 452 to 1343 1 to 886 L30X F75X M101X I112X I150X fully sequenced,   886/886
(100 %)
2 diff
(99.8 %id)
BM453093 leiomyosarcoma, uterus CMTM3.g 453 to 1276 52 to 877 exact     826/1094
(75 %)
22 diff
(98.0 %id)
BM545926 ovary (pool of 3) CMTM3.g 453 to 1422 14 to 986 exact     973/1129
(86 %)
18 diff
(98.5 %id)
BG421676 Kidney, renal cell adenocarcinoma CMTM3.g 454 to 1186 1 to 738 E174D     738/914
(80 %)
13 diff
(98.6 %id)
BI562351 testis CMTM3.g 454 to 1113 7 to 667 D9T P10G D11P P12E E13P ...     661/673
(98 %)
19 diff
(97.2 %id)
BM927256 brain CMTM3.g 454 to 1186 1 to 739 D162G S163L A164C D165R E166*     739/1083
(68 %)
17 diff
(98.5 %id)
CB996581 placenta, pre-eclamptic placenta CMTM3.g 454 to 1160 28 to 741 F53V     714/810
(88 %)
19 diff
(97.7 %id)
CB996368 placenta, pre-eclamptic placenta CMTM3.g 454 to 892 29 to 466       438/479
(91 %)
11 diff
(97.8 %id)
TI_44350250   CMTM3.g 454 to 1113 120 to 780 D9T P10G D11P P12E E13P ...     661/786
(84 %)
23 diff
(97.1 %id)
DB111484 thymus CMTM3.g 457 to 965 2 to 510   capped   509/509
(100 %)
1 diff
(99.9 %id)
CR986415 T-Lymphocytes CMTM3.g 460 to 1138 1 to 679 exact     679/682
(99 %)
2 diff
(99.8 %id)
BI759674 pooled colon, kidney, stomach CMTM3.g 461 to 1250 1 to 799 W2M P3W D5P P6*     799/799
(100 %)
32 diff
(96.0 %id)
TI_57148353   CMTM3.g 461 to 1250 35 to 833 W2M P3W D5P P6*     799/833
(95 %)
31 diff
(96.3 %id)
BG718261 testis CMTM3.g 462 to 1074 6 to 622 A61D S62V S63L A64S S65I ...     617/623
(99 %)
14 diff
(97.8 %id)
BQ919974 carcinoma, cell line, Prostate CMTM3.g 462 to 1372 36 to 955 W2G P3L P4L D5T D7T ...     920/984
(93 %)
22 diff
(97.8 %id)
BU502720 carcinoma, cell line, Prostate CMTM3.g 462 to 1045 26 to 612       587/1091
(53 %)
24 diff
(97.9 %id)
BU542240 carcinoma, cell line, Prostate CMTM3.g 462 to 1256 36 to 840 K171Q     805/950
(84 %)
26 diff
(97.3 %id)
BF726556 eye, lens CMTM3.g 463 to 985 1 to 523       523/523
(100 %)
0 diff
(100 %id)
CR619122 Placenta Cot 25-normalized CMTM3.g 463 to 2289 1 to 1827 exact     1827/1827
(100 %)
0 diff
(100 %id)
AL544210 placenta, Placenta Cot 25-normalized CMTM3.g 463 to 1512 1 to 1031 P3X D5X R28X S49X L51X ...     1031/1087
(94 %)
24 diff
(97.8 %id)
BX364819 Placenta Cot 25-normalized CMTM3.g 463 to 1442 1 to 966 P3X S49X S52X     966/1053
(91 %)
17 diff
(98.4 %id)
BQ893968 dorsal root ganglia CMTM3.g 464 to 1190 10 to 743 Y124H D162G S163L A164C D165R ...     734/1003
(73 %)
33 diff
(96.8 %id)
BQ719919 sympathetic trunk CMTM3.g 464 to 1102 13 to 652 V142A K159T E166D A169G K171*     640/930
(68 %)
22 diff
(97.7 %id)
BQ956538 large cell carcinoma, lung CMTM3.g 465 to 1362 1 to 903 E175N N176S S177D D178S S179D ...     906/941
(96 %)
11 diff
(98.9 %id)
BU543936 carcinoma, cell line, Prostate CMTM3.g 467 to 1266 1 to 811 exact     811/935
(86 %)
28 diff
(97.1 %id)
BX394208 Neuroblastoma Cot 25-normalized CMTM3.g 468 to 1366 1 to 889 P3X D5X A47X fully sequenced,   889/889
(100 %)
6 diff
(99.4 %id)
BX358501 Placenta Cot 25-normalized CMTM3.g 468 to 986 1 to 517       517/517
(100 %)
8 diff
(98.5 %id)
BX388131   CMTM3.g 468 to 1308 1 to 843 P3X D5G D7X D9X P14X ... fully sequenced,   843/843
(100 %)
26 diff
(97.0 %id)
TI_57203017   CMTM3.g 468 to 1123 55 to 734 W2G P4Q D5Y D11E E13D ...     675/967
(69 %)
34 diff
(96.5 %id)
BX424909 placenta CMTM3.g 469 to 1325 1 to 858 P3X D11G I57X E74G Y80F ...     858/858
(100 %)
6 diff
(99.4 %id)
CR618108 T cells (Jurkat cell line) Cot10-normalized CMTM3.g 469 to 2152 1 to 1684 exact     1684/1684
(100 %)
0 diff
(100 %id)
BX383396   CMTM3.g 469 to 1332 1 to 862 P3X D5X A15E S18L R19P ... fully sequenced,   862/862
(100 %)
7 diff
(99.2 %id)
CR594798 Neuroblastoma Cot 25-normalized CMTM3.g 470 to 2169 1 to 1700 exact     1700/1700
(100 %)
0 diff
(100 %id)
CR606566 B cells (Ramos cell line) Cot 25-normalized CMTM3.g 470 to 2150 1 to 1681 exact     1681/1681
(100 %)
0 diff
(100 %id)
CR613081 Neuroblastoma Cot 25-normalized CMTM3.g 470 to 2123 1 to 1654 exact     1654/1654
(100 %)
0 diff
(100 %id)
CR616563 Placenta Cot 25-normalized CMTM3.g 470 to 2046 1 to 1577 exact     1577/1577
(100 %)
0 diff
(100 %id)
BX354021 Neuroblastoma Cot 25-normalized CMTM3.g 470 to 1386 1 to 917 P3X D5X fully sequenced, AAA   917/917
(100 %)
2 diff
(99.8 %id)
BX387716 Placenta Cot 25-normalized CMTM3.g 470 to 1133 1 to 669 G161C D162A S163H A164S D165S ...     640/801
(79 %)
16 diff
(98.1 %id)
AL551269 placenta, Placenta Cot 25-normalized CMTM3.g 470 to 1346 1 to 866 W2A P4R D5P P6R D7P ... fully sequenced,   866/866
(100 %)
6 diff
(99.4 %id)
BX380438 Placenta Cot 25-normalized CMTM3.g 470 to 1248 1 to 770 exact fully sequenced,   770/770
(100 %)
5 diff
(99.4 %id)
BX360179 Placenta Cot 25-normalized CMTM3.g 470 to 1280 1 to 811 P3X R34X A35X L46X A47X ...     671/892
(75 %)
50 diff
(94.4 %id)
BM906504 ovary (pool of 3) CMTM3.g 470 to 1205 13 to 757 F135L I150N     745/1127
(66 %)
23 diff
(98.0 %id)
TI_57145998   CMTM3.g 470 to 1184 25 to 749 P8H D11E P12A A15C G16R ...     725/749
(96 %)
33 diff
(95.6 %id)
CR621723 Placenta Cot 25-normalized CMTM3.g 471 to 2154 1 to 1684 exact     1684/1684
(100 %)
0 diff
(100 %id)
CV814154 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass CMTM3.g 471 to 1184 1 to 715 K159T     715/896
(79 %)
8 diff
(99.2 %id)
TI_57198748   CMTM3.g 471 to 1297 22 to 851 P10R D11T P12R E13A P14C ...     830/871
(95 %)
35 diff
(96.0 %id)
BX375105 Neuroblastoma Cot 25-normalized CMTM3.g 474 to 1512 1 to 1034 W2X P3X D5X     1034/1034
(100 %)
23 diff
(97.8 %id)
AL542357 placenta CMTM3.g 474 to 1590 1 to 1105 W2X P3X K41X     1105/1128
(97 %)
22 diff
(98.1 %id)
BX356518 Placenta Cot 25-normalized CMTM3.g 474 to 1336 1 to 862 W2X P3X L44X fully sequenced,   862/862
(100 %)
7 diff
(99.2 %id)
CR596167 Placenta Cot 25-normalized CMTM3.g 475 to 2138 1 to 1664 exact     1664/1664
(100 %)
0 diff
(100 %id)
CR599238 placenta CMTM3.g 475 to 2119 1 to 1645 exact     1645/1645
(100 %)
0 diff
(100 %id)
CT002196 T-Lymphocytes CMTM3.g 476 to 1110 1 to 636 D180E S181L D182*     636/640
(99 %)
3 diff
(99.6 %id)
BI822650 pooled brain, lung, testis CMTM3.g 477 to 1297 1 to 824 P10R D11T P12R E13A P14C ...     824/844
(97 %)
39 diff
(95.4 %id)
BC023509 Placenta, choriocarcinoma CMTM3.g 478 to 2181 1 to 1704 exact available from MGC, AAA   1704/1704
(100 %)
0 diff
(100 %id)
BE903562 choriocarcinoma, placenta CMTM3.g 478 to 1043 41 to 608       568/937
(60 %)
26 diff
(97.3 %id)
BE903609 choriocarcinoma, placenta CMTM3.g 478 to 1203 35 to 750 D9T P10G D11P P12E E13P ...     716/905
(79 %)
11 diff
(98.8 %id)
BI819778 pooled brain, lung, testis CMTM3.g 478 to 1123 1 to 672 W2V P3A D5S P6T D7P ...     667/905
(73 %)
47 diff
(94.9 %id)
BI759175 pooled colon, kidney, stomach CMTM3.g 478 to 1184 1 to 718 P8H D11E P12A A15C G16R ...     718/718
(100 %)
36 diff
(95.0 %id)
CB994359 placenta, pre-eclamptic placenta CMTM3.g 478 to 1205 28 to 759 L158F     732/819
(89 %)
19 diff
(97.7 %id)
BM920223 pooled pancreas and spleen CMTM3.g 479 to 1441 1 to 970 exact     970/1023
(94 %)
27 diff
(97.4 %id)
DR007073 Spleen CMTM3.g 479 to 1188 1 to 712 D146E     712/713
(99 %)
7 diff
(99.1 %id)
CR978232 T-Lymphocytes CMTM3.g 480 to 795 1 to 317       317/317
(100 %)
2 diff
(99.4 %id)
BG748053 eye, normal pigmented retinal epithelium CMTM3.g 481 to 1335 1 to 848 A169V     848/853
(99 %)
14 diff
(98.4 %id)
BX280358 leiomyosarcoma, uterus CMTM3.g 483 to 994 1 to 512       512/512
(100 %)
0 diff
(100 %id)
BX383284   CMTM3.g 483 to 1355 1 to 876 W2X P3X A33T G42S L44X ... AAA   876/876
(100 %)
42 diff
(95.3 %id)
BQ068255 brain CMTM3.g 483 to 1190 15 to 725 exact     711/1089
(65 %)
18 diff
(98.4 %id)
CN403993 embryonic stem cells, DMSO-treated H9 cellline CMTM3.g 485 to 948 1 to 464       464/464
(100 %)
0 diff
(100 %id)
BC023591 Lung, large cell carcinoma CMTM3.g 486 to 2170 1 to 1685 exact available from MGC, AAA   1685/1685
(100 %)
0 diff
(100 %id)
TI_57239220   CMTM3.g 486 to 1133 24 to 677 D9V G17W G26W L27A R28P ...     654/757
(86 %)
27 diff
(96.5 %id)
BQ440402 leiomyosarcoma, uterus CMTM3.g 487 to 1295 1 to 822 exact     822/842
(97 %)
18 diff
(97.9 %id)
BG828846 muscle, rhabdomyosarcoma CMTM3.g 489 to 1118 1 to 632 F143Y A169G     632/690
(91 %)
7 diff
(99.0 %id)
CN403991 embryonic stem cells, DMSO-treated H9 cellline CMTM3.g 490 to 946 1 to 457       457/457
(100 %)
1 diff
(99.8 %id)
BI915493 brain CMTM3.g 491 to 1133 1 to 649 D9V G17W G26W L27A R28P ...     649/729
(89 %)
32 diff
(95.7 %id)
CR593528 Neuroblastoma Cot 25-normalized CMTM3.g 494 to 2149 1 to 1656 exact     1656/1656
(100 %)
0 diff
(100 %id)
BX394842 Neuroblastoma Cot 25-normalized CMTM3.g 494 to 1286 1 to 785 P3X D5X C38X D91X fully sequenced,   785/785
(100 %)
0 diff
(100 %id)
CX753752 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass CMTM3.g 495 to 1234 1 to 740 exact   Submitted on the opposite strand 740/740
(100 %)
5 diff
(99.4 %id)
CR974892 T-Lymphocytes CMTM3.g 495 to 1143 1 to 649 exact     649/649
(100 %)
1 diff
(99.9 %id)
CR988826 T-Lymphocytes CMTM3.g 495 to 1264 1 to 770 exact     770/771
(99 %)
5 diff
(99.4 %id)
CR606357 Neuroblastoma Cot 25-normalized CMTM3.g 496 to 2124 1 to 1629 exact     1629/1629
(100 %)
0 diff
(100 %id)
AL527977 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized CMTM3.g 496 to 1321 1 to 828 P3X D5E P6X D7X R19X ... fully sequenced,   828/828
(100 %)
6 diff
(99.3 %id)
BE747130 adenocarcinoma cell line, ovary CMTM3.g 496 to 1349 1 to 853 F135L G136A F137S F138L A139L ...     853/1031
(82 %)
40 diff
(96.2 %id)
BQ924873 large cell carcinoma, lung CMTM3.g 503 to 1110 1 to 612 F143L A155G K156Q F157I L158P ...     612/1041
(58 %)
17 diff
(98.4 %id)
EL734249 mixed CMTM3.g 526 to 1080 1 to 555 T168A K171*     555/673
(82 %)
8 diff
(98.9 %id)
CR589961 Neuroblastoma Cot 25-normalized CMTM3.g 536 to 2260 1 to 1725       1725/1725
(100 %)
0 diff
(100 %id)
BX354638 Neuroblastoma Cot 25-normalized CMTM3.g 536 to 1421 1 to 872   fully sequenced,   872/872
(100 %)
0 diff
(100 %id)
BI087043 cervix CMTM3.g 536 to 1394 8 to 873       866/904
(95 %)
39 diff
(95.7 %id)
BM563036 brain, medulla CMTM3.g 542 to 1421 21 to 904       884/1076
(82 %)
27 diff
(97.5 %id)
BU150171 dorsal root ganglia CMTM3.g 550 to 1325 1 to 781       781/870
(89 %)
15 diff
(98.3 %id)
BI752898 brain CMTM3.g 566 to 1043 107 to 590       484/744
(65 %)
23 diff
(97.0 %id)
TI_57219722   CMTM3.g 566 to 1043 254 to 737       484/891
(54 %)
25 diff
(97.2 %id)
CX757889 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass CMTM3.g 578 to 1306 1 to 729     Submitted on the opposite strand 729/730
(99 %)
7 diff
(99.1 %id)
CD514412 White Matter CMTM3.g 601 to 1433 1 to 834       834/841
(99 %)
4 diff
(99.6 %id)
BI518832 leukocyte CMTM3.g 602 to 1184 57 to 693 W2L P10L D11T P12R E13V ...     606/693
(87 %)
27 diff
(96.2 %id)
TI_44459253   CMTM3.g 602 to 1184 87 to 723 W2L P10L D11T P12R E13V ...     604/723
(83 %)
27 diff
(96.3 %id)
BX952540   CMTM3.g 638 to 1281 1 to 644       644/644
(100 %)
1 diff
(99.9 %id)
AW327517 blood, T cell leukemia CMTM3.g 645 to 1204 1 to 560       560/560
(100 %)
1 diff
(99.9 %id)
BY994870   CMTM3.g 673 to 1163 248 to 738       491/738
(66 %)
6 diff
(99.2 %id)
BG251098 adenocarcinoma, cell line, Liver CMTM3.g 676 to 1413 1 to 732       732/932
(78 %)
14 diff
(98.5 %id)
AK075075 placenta CMTM3.g 687 to 2317 1 to 1631   available from FLJ,   1631/1631
(100 %)
3 diff
(99.9 %id)
DA828454 placenta CMTM3.g 688 to 1371 2 to 689   capped   688/700
(98 %)
9 diff
(98.8 %id)
DR006529 Spleen CMTM3.g 693 to 1423 1 to 731       731/731
(100 %)
1 diff
(99.9 %id)
AL042115 testis CMTM3.g 706 to 1285 1 to 575       575/578
(99 %)
14 diff
(97.6 %id)
BQ953418 leiomyosarcoma, uterus CMTM3.g 707 to 1325 1 to 631       631/1253
(50 %)
16 diff
(98.8 %id)
BU855029 ovary, teratocarcinoma, cell line CMTM3.g 707 to 1563 1 to 865       865/906
(95 %)
19 diff
(98.0 %id)
BP337309 coronary artery CMTM3.g 738 to 1325 1 to 588       588/588
(100 %)
2 diff
(99.7 %id)
BP367481 thymus CMTM3.g 771 to 1352 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BF813945 colon_ins CMTM3.g 791 to 1193 411 to 10     Submitted on the opposite strand 402/411
(97 %)
0 diff
(100 %id)
BU599202 mixed (pool of 40 RNAs) CMTM3.g 794 to 1477 1 to 695       695/783
(88 %)
23 diff
(97.1 %id)
Z46193 brain, total brain CMTM3.g 799 to 1111 1 to 313       313/313
(100 %)
0 diff
(100 %id)
R14227 whole brain CMTM3.g 799 to 1163 1 to 371       371/440
(84 %)
11 diff
(97.5 %id)
H15332 whole brain CMTM3.g 800 to 1388 1 to 593       593/593
(100 %)
31 diff
(94.8 %id)
BF813939 colon_ins CMTM3.g 879 to 1212 334 to 1     Submitted on the opposite strand 334/334
(100 %)
3 diff
(99.2 %id)
CD518077 White Matter CMTM3.g 884 to 1549 18 to 687       670/932
(71 %)
15 diff
(98.4 %id)
CD559142 White Matter CMTM3.g 893 to 1624 27 to 766       740/933
(79 %)
19 diff
(98.0 %id)
CN403998 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells CMTM3.g 899 to 1534 1 to 637       637/637
(100 %)
4 diff
(99.4 %id)
BG323505 Kidney, renal cell adenocarcinoma CMTM3.g 907 to 1675 1 to 765       765/770
(99 %)
9 diff
(98.9 %id)
BG323663 Kidney, renal cell adenocarcinoma CMTM3.g 907 to 1681 1 to 774       774/800
(96 %)
11 diff
(98.7 %id)
BG697860 skin CMTM3.g 959 to 1720 1 to 764       764/764
(100 %)
7 diff
(99.1 %id)
BE907226 epithelioid carcinoma, Pancreas CMTM3.g 967 to 1576 1 to 612       612/613
(99 %)
3 diff
(99.6 %id)
BI199176 brain, neuroblastoma CMTM3.g 987 to 1779 1 to 794       794/796
(99 %)
10 diff
(98.8 %id)
BF981832 duodenal adenocarcinoma, cell line, small intestine CMTM3.g 988 to 1767 1 to 773       773/1008
(76 %)
31 diff
(97.0 %id)
AW957722   CMTM3.g 990 to 1615 4 to 630       627/630
(99 %)
11 diff
(98.3 %id)
BG744169 blood, natural killer cells, cell line CMTM3.g 996 to 1634 1 to 626   fully sequenced,   626/626
(100 %)
3 diff
(99.6 %id)
AA351880 brain CMTM3.g 998 to 1328 1 to 331       331/331
(100 %)
0 diff
(100 %id)
BM918233 blood, natural killer cells, cell line CMTM3.g 999 to 1674 1 to 677       677/1047
(64 %)
20 diff
(98.1 %id)
BQ054182 blood, natural killer cells, cell line CMTM3.g 999 to 1977 1 to 984       984/1033
(95 %)
27 diff
(97.4 %id)
AL550323 placenta, Placenta Cot 25-normalized CMTM3.g 1000 to 1345 22 to 363   fully sequenced,   342/363
(94 %)
13 diff
(96.5 %id)
AL047917 uterus CMTM3.g 1028 to 1342 1 to 316       316/316
(100 %)
2 diff
(99.4 %id)
BG758446 B-cells, primary B-cells from tonsils (cell line) CMTM3.g 1028 to 1963 1 to 931       931/934
(99 %)
19 diff
(98.0 %id)
BG116095 duodenal adenocarcinoma, cell line, small intestine CMTM3.g 1046 to 1786 1 to 731       731/972
(75 %)
13 diff
(98.7 %id)
BU173146 eye, retinoblastoma CMTM3.g 1048 to 1969 11 to 950       940/954
(98 %)
44 diff
(95.4 %id)
BX101320 liver and spleen CMTM3.g 1053 to 1759 1 to 707       707/707
(100 %)
0 diff
(100 %id)
W88602 liver and spleen CMTM3.g 1053 to 1516 1 to 461       461/462
(99 %)
15 diff
(96.8 %id)
BF665058 brain, primitive neuroectoderm CMTM3.g 1056 to 1780 1 to 710       710/710
(100 %)
39 diff
(94.6 %id)
BX365300 Placenta Cot 25-normalized CMTM3.g 1057 to 2145 1078 to 1       1078/1089
(98 %)
36 diff
(96.7 %id)
CB265552 adipose CMTM3.g 1079 to 1592 1 to 514       514/514
(100 %)
0 diff
(100 %id)
CB269852 adipose CMTM3.g 1084 to 1744 1 to 657       657/658
(99 %)
9 diff
(98.7 %id)
BX365162 Placenta Cot 25-normalized CMTM3.g 1104 to 2137 1020 to 1       1020/1020
(100 %)
37 diff
(96.4 %id)
CN403995 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 CMTM3.g 1107 to 1708 1 to 602       602/602
(100 %)
0 diff
(100 %id)
BG120208 adenocarcinoma, cell line, Liver CMTM3.g 1110 to 1829 1 to 714       714/912
(78 %)
10 diff
(99.0 %id)
BX339363 Placenta Cot 25-normalized CMTM3.g 1116 to 2153 1034 to 1       1034/1094
(94 %)
17 diff
(98.5 %id)
AL574328 placenta, Placenta Cot 25-normalized CMTM3.g 1117 to 2128 1010 to 11       1000/1010
(99 %)
0 diff
(100 %id)
BF528462 anaplastic oligodendroglioma with 1p/19qloss, brain CMTM3.g 1120 to 1902 1 to 791       791/847
(93 %)
44 diff
(94.9 %id)
BE893035 melanotic melanoma, skin CMTM3.g 1130 to 1823 1 to 696       696/925
(75 %)
10 diff
(99.0 %id)
BX340465   CMTM3.g 1134 to 2182 1 to 1040       1040/1040
(100 %)
17 diff
(98.4 %id)
BX385942 Placenta Cot 25-normalized CMTM3.g 1150 to 2153 991 to 1       991/1049
(94 %)
23 diff
(97.9 %id)
CR745975 ovarian tumor, ovary CMTM3.g 1151 to 1857 1 to 707       707/707
(100 %)
1 diff
(99.9 %id)
CN403988 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 CMTM3.g 1152 to 1744 1 to 593       593/593
(100 %)
0 diff
(100 %id)
AA291082 ovarian tumor, ovary CMTM3.g 1167 to 1477 14 to 316       303/316
(95 %)
7 diff
(97.8 %id)
BQ614483 insulinoma, Pancreas CMTM3.g 1174 to 1704 1 to 532       532/532
(100 %)
5 diff
(99.1 %id)
CN403986 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 CMTM3.g 1180 to 1883 1 to 704       704/704
(100 %)
4 diff
(99.5 %id)
AL569378 placenta CMTM3.g 1216 to 1822 902 to 296       607/1058
(57 %)
0 diff
(100 %id)
AA448053   CMTM3.g 1232 to 1496 1 to 263       263/263
(100 %)
3 diff
(98.9 %id)
AA447041   CMTM3.g 1242 to 1640 8 to 405       398/405
(98 %)
6 diff
(98.6 %id)
BX394841 Neuroblastoma Cot 25-normalized CMTM3.g 1256 to 2149 884 to 1   fully sequenced,   884/884
(100 %)
17 diff
(98.1 %id)
CN403989 embryonic stem cells, DMSO-treated H9 cellline CMTM3.g 1263 to 1562 1 to 300       300/300
(100 %)
0 diff
(100 %id)
AL570495 placenta, Placenta Cot 25-normalized CMTM3.g 1265 to 2285 1021 to 1       1021/1105
(92 %)
13 diff
(98.9 %id)
BI018341 marrow CMTM3.g 1275 to 1635 1 to 360       360/360
(100 %)
4 diff
(98.9 %id)
BX324980   CMTM3.g 1276 to 2145 867 to 1   fully sequenced,   867/867
(100 %)
22 diff
(97.5 %id)
BX388130   CMTM3.g 1278 to 2150 871 to 1   fully sequenced,   871/871
(100 %)
18 diff
(98.0 %id)
AL527976 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized CMTM3.g 1284 to 2124 840 to 1   fully sequenced,   840/840
(100 %)
13 diff
(98.5 %id)
AW352206 head_neck CMTM3.g 1296 to 1716 1 to 421       421/422
(99 %)
10 diff
(97.7 %id)
BX383395   CMTM3.g 1302 to 2129 844 to 18   fully sequenced,   827/844
(97 %)
9 diff
(99.0 %id)
CX761625 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass CMTM3.g 1304 to 2078 1 to 767     Submitted on the opposite strand 767/769
(99 %)
9 diff
(98.9 %id)
AL570361 placenta, Placenta Cot 25-normalized CMTM3.g 1305 to 2141 832 to 1       832/841
(98 %)
49 diff
(94.2 %id)
BX356517 Placenta Cot 25-normalized CMTM3.g 1306 to 2055 835 to 83   fully sequenced,   753/835
(90 %)
16 diff
(98.1 %id)
BG025328 lymph, lymphoma, cell line CMTM3.g 1307 to 2106 1 to 788       788/866
(90 %)
16 diff
(98.2 %id)
BX376201 Neuroblastoma Cot 25-normalized CMTM3.g 1313 to 2140 829 to 11   fully sequenced,   819/829
(98 %)
54 diff
(93.5 %id)
AL574900 placenta, Placenta Cot 25-normalized CMTM3.g 1316 to 2154 830 to 1   fully sequenced,   830/830
(100 %)
8 diff
(99.1 %id)
BM739563 stomach CMTM3.g 1316 to 1911 1 to 597       597/597
(100 %)
14 diff
(97.7 %id)
BM835914 stomach CMTM3.g 1316 to 1768 1 to 449       449/449
(100 %)
3 diff
(99.4 %id)
BM839027 stomach CMTM3.g 1316 to 1712 1 to 397       397/397
(100 %)
2 diff
(99.5 %id)
BM738561 stomach CMTM3.g 1320 to 1771 1 to 449       449/449
(100 %)
5 diff
(98.9 %id)
CN403997 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 CMTM3.g 1321 to 1852 1 to 532       532/532
(100 %)
0 diff
(100 %id)
AA339237 brain CMTM3.g 1322 to 1633 1 to 312       312/315
(99 %)
1 diff
(99.7 %id)
AW952799   CMTM3.g 1322 to 1823 1 to 502       502/503
(99 %)
5 diff
(99.1 %id)
BX394207 Neuroblastoma Cot 25-normalized CMTM3.g 1336 to 2169 821 to 1   fully sequenced,   821/821
(100 %)
2 diff
(99.8 %id)
AA058429 uterus CMTM3.g 1337 to 1891 1 to 559   fully sequenced,   559/559
(100 %)
8 diff
(98.6 %id)
BX354020 Neuroblastoma Cot 25-normalized CMTM3.g 1356 to 1852 807 to 318   fully sequenced,   490/807
(60 %)
6 diff
(99.3 %id)
BX364818 Placenta Cot 25-normalized CMTM3.g 1366 to 2289 912 to 1       912/955
(95 %)
20 diff
(98.0 %id)
W25565 lung CMTM3.g 1375 to 1750 1 to 384   fully sequenced,   384/384
(100 %)
11 diff
(97.2 %id)
BX380437 Placenta Cot 25-normalized CMTM3.g 1376 to 2046 674 to 1   fully sequenced,   796/796
(100 %)
30 diff
(96.3 %id)
BF337754 brain, glioblastoma with EGFR amplification CMTM3.g 1388 to 2099 1 to 708       708/775
(91 %)
21 diff
(97.3 %id)
AA486658 lung CMTM3.g 1390 to 1783 1 to 392       392/392
(100 %)
2 diff
(99.5 %id)
BX354637 Neuroblastoma Cot 25-normalized CMTM3.g 1391 to 2260 862 to 1   fully sequenced,   862/862
(100 %)
7 diff
(99.2 %id)
BF037986 adenocarcinoma, ovary CMTM3.g 1397 to 2134 1 to 728       728/730
(99 %)
15 diff
(98.0 %id)
BX435295 brain, fetal brain CMTM3.g 1399 to 2165 777 to 1       777/867
(89 %)
16 diff
(98.2 %id)
AA127629 uterus CMTM3.g 1399 to 1745 1 to 345   fully sequenced,   345/345
(100 %)
3 diff
(99.2 %id)
CR738774 uterus CMTM3.g 1400 to 2054 1 to 655       655/655
(100 %)
0 diff
(100 %id)
BQ053086 blood, natural killer cells, cell line CMTM3.g 1404 to 2061 1 to 661       661/1020
(64 %)
20 diff
(98.1 %id)
TI_149293807   CMTM3.g 1404 to 2181 845 to 78   AAA   768/960
(80 %)
21 diff
(97.9 %id)
CA309177 Alveolar Macrophage, lung CMTM3.g 1413 to 2181 780 to 19   AAA   762/762
(100 %)
10 diff
(98.7 %id)
CN403990 embryonic stem cells, DMSO-treated H9 cellline CMTM3.g 1424 to 2044 1 to 621       621/621
(100 %)
3 diff
(99.6 %id)
TI_149285974   CMTM3.g 1427 to 2183 832 to 84   AAA   749/808
(92 %)
16 diff
(98.1 %id)
BI520905 brain, medulla CMTM3.g 1436 to 2097 669 to 2       668/669
(99 %)
0 diff
(100 %id)
TI_43963344   CMTM3.g 1436 to 2097 669 to 2       668/669
(99 %)
0 diff
(100 %id)
BX330862.
matches multiple genes
  CMTM3.g 1439 to 2089 658 to 5     also hits gene COPS7B 654/755
(86 %)
0 diff
(100 %id)
CN403996 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 CMTM3.g 1443 to 2044 1 to 602       602/602
(100 %)
2 diff
(99.7 %id)
TI_149292471   CMTM3.g 1447 to 2183 801 to 78   AAA   724/885
(81 %)
14 diff
(98.5 %id)
AA214738   CMTM3.g 1448 to 1786 1 to 336       336/336
(100 %)
10 diff
(97.1 %id)
AV717137   CMTM3.g 1456 to 2013 38 to 593       556/656
(84 %)
41 diff
(93.8 %id)
CA308811 Alveolar Macrophage, lung CMTM3.g 1465 to 2175 727 to 19   AAA   709/709
(100 %)
2 diff
(99.8 %id)
TI_154034055   CMTM3.g 1467 to 2317 919 to 83   AAA   837/961
(87 %)
13 diff
(98.7 %id)
BF038419 adenocarcinoma, ovary CMTM3.g 1469 to 2039 1 to 567       567/571
(99 %)
19 diff
(96.7 %id)
BQ014772 Chondrosarcoma, Left Pubic Bone CMTM3.g 1471 to 2170 718 to 19   AAA   700/715
(97 %)
0 diff
(100 %id)
BX392723 Placenta Cot 25-normalized CMTM3.g 1473 to 2180 705 to 1       705/882
(79 %)
16 diff
(98.2 %id)
AA099632 uterus CMTM3.g 1475 to 1799 1 to 327   fully sequenced,   327/327
(100 %)
6 diff
(98.2 %id)
BF092265 testis_normal CMTM3.g 1477 to 1930 460 to 11       450/484
(92 %)
0 diff
(100 %id)
T56924 fetal spleen, Spleen CMTM3.g 1485 to 1863 1 to 379       379/379
(100 %)
11 diff
(97.1 %id)
BU622946 cell lines, Chondrosarcoma CMTM3.g 1485 to 2181 713 to 19   AAA   695/699
(99 %)
2 diff
(99.8 %id)
AA352595   CMTM3.g 1487 to 1904 1 to 412       412/467
(88 %)
13 diff
(97.3 %id)
AV756005 bone marrow CMTM3.g 1503 to 2150 101 to 745       645/656
(98 %)
3 diff
(99.6 %id)
FN087898 breast carcinoma CMTM3.g 1509 to 1608 1 to 104       104/104
(100 %)
4 diff
(96.2 %id)
BQ008437 Chondrosarcoma, Left Pubic Bone CMTM3.g 1515 to 2181 685 to 19   AAA   667/667
(100 %)
0 diff
(100 %id)
BU601320 mixed (pool of 40 RNAs) CMTM3.g 1515 to 2180 1 to 665       665/671
(99 %)
4 diff
(99.5 %id)
BU682824 lung CMTM3.g 1524 to 2181 676 to 19   AAA   658/662
(99 %)
3 diff
(99.6 %id)
BQ004224 Chondrosarcoma, Left Pelvis CMTM3.g 1532 to 2177 662 to 17   AAA   646/646
(100 %)
0 diff
(100 %id)
AV693706 hepatocellular carcinoma CMTM3.g 1552 to 1929 1 to 373       373/374
(99 %)
3 diff
(99.2 %id)
BM476701 leiomyosarcoma, uterus CMTM3.g 1555 to 2181 1 to 627   AAA   627/627
(100 %)
2 diff
(99.7 %id)
BF382605 brain, primitive neuroectoderm CMTM3.g 1563 to 2180 1 to 613       613/886
(69 %)
34 diff
(96.2 %id)
AA121524 uterus CMTM3.g 1565 to 2170 608 to 1       608/608
(100 %)
8 diff
(98.7 %id)
BP428874   CMTM3.g 1567 to 1985 1 to 419       419/419
(100 %)
3 diff
(99.3 %id)
BX417035 placenta CMTM3.g 1577 to 2183 1 to 607       607/607
(100 %)
5 diff
(99.2 %id)
BU682418 lung CMTM3.g 1578 to 2183 619 to 17   AAA   603/603
(100 %)
4 diff
(99.4 %id)
TI_57182816   CMTM3.g 1580 to 2176 59 to 656       598/835
(71 %)
6 diff
(99.3 %id)
TI_149306018   CMTM3.g 1581 to 2323 808 to 77   AAA   732/890
(82 %)
9 diff
(99.0 %id)
CA421948 Bone, Enchondroma cell line CMTM3.g 1583 to 2177 610 to 19   AAA   592/592
(100 %)
4 diff
(99.4 %id)
BI771429 pooled lung and spleen CMTM3.g 1590 to 2176 1 to 588       588/767
(76 %)
7 diff
(99.1 %id)
BG744833 blood, natural killer cells, cell line CMTM3.g 1604 to 2137 534 to 1   fully sequenced,   534/534
(100 %)
5 diff
(99.1 %id)
AA522819 lung, lung tumor CMTM3.g 1613 to 2181 559 to 1       559/559
(100 %)
11 diff
(98.1 %id)
TI_159709175   CMTM3.g 1616 to 2170 643 to 88   AAA   556/1010
(55 %)
49 diff
(95.2 %id)
BF382067 brain, primitive neuroectoderm CMTM3.g 1617 to 2157 1 to 541   AAA   541/559
(96 %)
4 diff
(99.3 %id)
BF541725 hypernephroma, Kidney CMTM3.g 1617 to 2172 1 to 556       556/588
(94 %)
24 diff
(96.0 %id)
R79538 placenta CMTM3.g 1621 to 2060 1 to 448       448/452
(99 %)
12 diff
(97.4 %id)
BG231643 blood, lymphocyte CMTM3.g 1629 to 2098 470 to 1       470/470
(100 %)
0 diff
(100 %id)
BU686202 lung, Primary Lung Epithelial Cells CMTM3.g 1632 to 2323 706 to 19   AAA   688/704
(97 %)
4 diff
(99.5 %id)
BG231815 blood, lymphocyte CMTM3.g 1633 to 2170 538 to 1       538/538
(100 %)
0 diff
(100 %id)
TI_57228666   CMTM3.g 1644 to 2322 55 to 734       680/680
(100 %)
3 diff
(99.6 %id)
BI869447 adenocarcinoma, cell line, Liver CMTM3.g 1645 to 2322 1 to 679       679/679
(100 %)
3 diff
(99.6 %id)
BM971810 lung CMTM3.g 1646 to 2183 554 to 17   AAA   538/538
(100 %)
0 diff
(100 %id)
BQ446404 Knee, Osteoarthritic Cartilage CMTM3.g 1646 to 2175 548 to 19   AAA   530/530
(100 %)
0 diff
(100 %id)
AI310156 2 pooled tumors (clear cell type), Kidney CMTM3.g 1647 to 2182 538 to 3       536/538
(99 %)
0 diff
(100 %id)
AI653011 pooled germ cell tumors CMTM3.g 1650 to 2176 533 to 7       527/533
(98 %)
0 diff
(100 %id)
AI816920 2 pooled tumors (clear cell type), Kidney CMTM3.g 1650 to 2172 524 to 2       523/524
(99 %)
0 diff
(100 %id)
BF059268 pooled germ cell tumors CMTM3.g 1650 to 2181 531 to 1       531/531
(100 %)
2 diff
(99.7 %id)
N36538 melanocyte CMTM3.g 1651 to 2178 1 to 534       534/536
(99 %)
13 diff
(97.6 %id)
AI885185 anaplastic oligodendroglioma, brain CMTM3.g 1651 to 2184 534 to 1       534/534
(100 %)
0 diff
(100 %id)
BF196680 brain, glioblastoma (pooled) CMTM3.g 1660 to 2181 522 to 1       522/522
(100 %)
0 diff
(100 %id)
BM145699 leukopheresis CMTM3.g 1664 to 2182 535 to 17   AAA   519/519
(100 %)
4 diff
(99.3 %id)
AI703500 carcinoid, lung CMTM3.g 1670 to 2170 501 to 1       501/501
(100 %)
2 diff
(99.7 %id)
AL550485 placenta, Placenta Cot 25-normalized CMTM3.g 1671 to 1986 493 to 176   fully sequenced,   622/797
(78 %)
54 diff
(93.3 %id)
BX453832 placenta CMTM3.g 1673 to 2156 503 to 19       485/532
(91 %)
0 diff
(100 %id)
BX396299 Placenta Cot 25-normalized CMTM3.g 1673 to 2120 466 to 19       448/483
(92 %)
0 diff
(100 %id)
AI917727 pooled germ cell tumors CMTM3.g 1677 to 2183 507 to 1       507/507
(100 %)
0 diff
(100 %id)
CB118643 Liver CMTM3.g 1679 to 2181 521 to 19   AAA Submitted on the opposite strand 503/503
(100 %)
8 diff
(98.5 %id)
AV735997 cord Blood CMTM3.g 1684 to 2177 33 to 507   AAA   475/507
(93 %)
6 diff
(98.9 %id)
TI_149289192   CMTM3.g 1688 to 2317 721 to 92   AAA   630/637
(98 %)
0 diff
(100 %id)
N41512 melanocyte CMTM3.g 1689 to 1995 1 to 310       310/310
(100 %)
6 diff
(98.1 %id)
AA447649   CMTM3.g 1691 to 2182 496 to 5       492/496
(99 %)
0 diff
(100 %id)
AI569654 anaplastic oligodendroglioma, brain CMTM3.g 1692 to 2170 479 to 1       479/479
(100 %)
0 diff
(100 %id)
AI393275 B-cell, chronic lymphotic leukemia CMTM3.g 1695 to 2181 487 to 1       487/487
(100 %)
0 diff
(100 %id)
BP306565   CMTM3.g 1695 to 2181 1 to 487       487/565
(86 %)
7 diff
(98.8 %id)
AI129541 uterus CMTM3.g 1697 to 2177 481 to 1       481/481
(100 %)
0 diff
(100 %id)
BU565720 mixed (pool of 40 RNAs) CMTM3.g 1697 to 2180 1 to 482       482/515
(93 %)
3 diff
(99.5 %id)
DB528101 testis CMTM3.g 1700 to 2181 1 to 482     Submitted on the opposite strand 482/482
(100 %)
0 diff
(100 %id)
TI_154094790   CMTM3.g 1701 to 2170 586 to 115   AAA   472/1167
(40 %)
14 diff
(98.9 %id)
AI554669 anaplastic oligodendroglioma, brain CMTM3.g 1702 to 2175 487 to 14   AAA   474/474
(100 %)
0 diff
(100 %id)
AI651857 pooled germ cell tumors CMTM3.g 1702 to 2170 469 to 1       469/469
(100 %)
3 diff
(99.4 %id)
BF035607 adenocarcinoma, ovary CMTM3.g 1702 to 2182 1 to 480       480/487
(98 %)
2 diff
(99.6 %id)
AI769369 2 pooled tumors (clear cell type), Kidney CMTM3.g 1704 to 2177 485 to 12   AAA   474/474
(100 %)
5 diff
(99.0 %id)
BF058861 fibrotheoma, ovary CMTM3.g 1704 to 2181 478 to 1       478/478
(100 %)
0 diff
(100 %id)
CB123487 Liver CMTM3.g 1707 to 2181 493 to 19   AAA Submitted on the opposite strand 475/475
(100 %)
0 diff
(100 %id)
AI422130 brain, glioblastoma (pooled) CMTM3.g 1708 to 2181 472 to 1       472/472
(100 %)
4 diff
(99.2 %id)
BE467836 carcinoid, lung CMTM3.g 1708 to 2183 477 to 1       477/477
(100 %)
1 diff
(99.8 %id)
AA449605   CMTM3.g 1709 to 1818 7 to 114   fully sequenced,   108/114
(94 %)
0 diff
(100 %id)
AI597911 poorly differentiated adenocarcinoma withsignet ring cell features, stomach CMTM3.g 1709 to 2178 470 to 1       470/470
(100 %)
0 diff
(100 %id)
AI199561 anaplastic oligodendroglioma, brain CMTM3.g 1710 to 2181 483 to 12   AAA   472/472
(100 %)
0 diff
(100 %id)
BE222397 carcinoid, lung CMTM3.g 1711 to 2327 615 to 1       615/630
(97 %)
13 diff
(98.0 %id)
CB119462 Liver CMTM3.g 1711 to 2181 489 to 19   AAA Submitted on the opposite strand 471/471
(100 %)
7 diff
(98.6 %id)
AW468274 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood CMTM3.g 1714 to 2172 461 to 3       459/461
(99 %)
0 diff
(100 %id)
AA121531 uterus CMTM3.g 1715 to 2170 453 to 1   fully sequenced,   453/453
(100 %)
2 diff
(99.6 %id)
N92885 lung CMTM3.g 1720 to 2182 475 to 1   fully sequenced,   475/475
(100 %)
15 diff
(96.9 %id)
BF000345 colon, colon tumor, RER+ CMTM3.g 1720 to 2317 598 to 1       598/598
(100 %)
0 diff
(100 %id)
BQ276918 mixed (pool of 40 RNAs) CMTM3.g 1723 to 2184 1 to 462       462/955
(48 %)
2 diff
(99.8 %id)
AA694161 liver and spleen CMTM3.g 1725 to 2182 461 to 4       458/461
(99 %)
0 diff
(100 %id)
AI950367 2 pooled tumors (clear cell type), Kidney CMTM3.g 1726 to 2182 459 to 3       457/459
(99 %)
0 diff
(100 %id)
AA780184   CMTM3.g 1727 to 2172 448 to 3       446/448
(99 %)
0 diff
(100 %id)
AI422804 brain, glioblastoma (pooled) CMTM3.g 1728 to 2182 455 to 1       455/455
(100 %)
0 diff
(100 %id)
AA290675 ovarian tumor, ovary CMTM3.g 1731 to 2182 454 to 3       452/454
(99 %)
0 diff
(100 %id)
W69776 heart CMTM3.g 1734 to 2183 451 to 1       451/452
(99 %)
2 diff
(99.6 %id)
AI871310 anaplastic oligodendroglioma, brain CMTM3.g 1738 to 2183 446 to 1       446/446
(100 %)
0 diff
(100 %id)
BF437625 Prostate CMTM3.g 1738 to 2174 436 to 1       436/436
(100 %)
3 diff
(99.4 %id)
CD106751 brain, Pituitary CMTM3.g 1738 to 2183 1 to 446       446/481
(92 %)
1 diff
(99.8 %id)
CD107797 brain, Pituitary CMTM3.g 1738 to 2183 1 to 446       446/450
(99 %)
1 diff
(99.8 %id)
AW006534 Prostate CMTM3.g 1739 to 2176 447 to 9       439/447
(98 %)
0 diff
(100 %id)
AI990389 pooled germ cell tumors CMTM3.g 1748 to 2183 447 to 12   AAA   436/436
(100 %)
5 diff
(98.9 %id)
BX358500 Placenta Cot 25-normalized CMTM3.g 1750 to 2281 534 to 1       534/534
(100 %)
4 diff
(99.3 %id)
AI635393 pooled germ cell tumors CMTM3.g 1751 to 2182 437 to 6       432/437
(98 %)
0 diff
(100 %id)
AI631814 Kidney CMTM3.g 1760 to 2177 432 to 15   AAA   418/418
(100 %)
9 diff
(97.9 %id)
AW016914   CMTM3.g 1760 to 2181 439 to 18   AAA   422/422
(100 %)
1 diff
(99.8 %id)
BM929449 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid CMTM3.g 1763 to 2329 1 to 568   AAA   568/568
(100 %)
1 diff
(99.9 %id)
AW580950 leiomios CMTM3.g 1764 to 2132 367 to 1       367/367
(100 %)
13 diff
(96.5 %id)
BM970780 lung CMTM3.g 1766 to 2317 570 to 19   AAA   552/552
(100 %)
0 diff
(100 %id)
AL047918 uterus CMTM3.g 1768 to 2170 413 to 11   AAA   403/403
(100 %)
0 diff
(100 %id)
DB528250 hippocampus CMTM3.g 1769 to 2172 1 to 403     Submitted on the opposite strand 403/408
(98 %)
11 diff
(97.4 %id)
AA101965 uterus CMTM3.g 1769 to 2175 407 to 1   fully sequenced,   407/407
(100 %)
1 diff
(99.8 %id)
BU075618 insulinoma, Pancreas CMTM3.g 1771 to 2182 12 to 423     Submitted on the opposite strand 412/437
(94 %)
1 diff
(99.8 %id)
BU579795 insulinoma, Pancreas CMTM3.g 1771 to 2182 12 to 423     Submitted on the opposite strand 412/437
(94 %)
1 diff
(99.8 %id)
BU580047 insulinoma, Pancreas CMTM3.g 1771 to 2182 427 to 16     Submitted on the opposite strand 412/427
(96 %)
0 diff
(100 %id)
BU075811 insulinoma, Pancreas CMTM3.g 1772 to 2182 427 to 16     Submitted on the opposite strand 412/427
(96 %)
0 diff
(100 %id)
CA436568 Bone, Subchondral Bone CMTM3.g 1773 to 2170 416 to 19   AAA   398/398
(100 %)
3 diff
(99.3 %id)
BP396008 pancreatic islet CMTM3.g 1775 to 2181 1 to 408     Submitted on the opposite strand 408/408
(100 %)
2 diff
(99.6 %id)
DB323902   CMTM3.g 1775 to 2317 543 to 1       543/543
(100 %)
0 diff
(100 %id)
AA758972   CMTM3.g 1776 to 2178 410 to 9       402/410
(98 %)
0 diff
(100 %id)
AA602552 adrenal adenoma, adrenal gland CMTM3.g 1776 to 2172 400 to 5       396/400
(99 %)
0 diff
(100 %id)
AI424274 Prostate CMTM3.g 1777 to 2171 395 to 1       395/395
(100 %)
0 diff
(100 %id)
AI289186 2 pooled tumors (clear cell type), Kidney CMTM3.g 1778 to 2182 407 to 3       405/407
(99 %)
0 diff
(100 %id)
BM144908 leukopheresis CMTM3.g 1784 to 2181 417 to 19       399/417
(95 %)
0 diff
(100 %id)
DB372980 placenta CMTM3.g 1786 to 2317 533 to 1       533/533
(100 %)
20 diff
(96.3 %id)
AA449346   CMTM3.g 1788 to 2177 388 to 1   fully sequenced,   388/388
(100 %)
2 diff
(99.5 %id)
AI052494 liver and spleen CMTM3.g 1788 to 2181 394 to 1       394/394
(100 %)
0 diff
(100 %id)
AI336104 lung CMTM3.g 1788 to 2182 395 to 1       395/395
(100 %)
0 diff
(100 %id)
AI422522 brain, glioblastoma (pooled) CMTM3.g 1790 to 2181 393 to 1       393/393
(100 %)
1 diff
(99.8 %id)
BE716957 head_neck CMTM3.g 1791 to 2112 350 to 28       323/354
(91 %)
0 diff
(100 %id)
W88501 liver and spleen CMTM3.g 1791 to 2181 391 to 1       391/391
(100 %)
4 diff
(99.0 %id)
AI040930   CMTM3.g 1792 to 2172 382 to 2       381/382
(99 %)
0 diff
(100 %id)
AI128384 placenta CMTM3.g 1794 to 2187 394 to 1       394/394
(100 %)
0 diff
(100 %id)
T31813 colon, embryo CMTM3.g 1796 to 2181 387 to 1       387/391
(98 %)
1 diff
(99.8 %id)
AW590779 pooled germ cell tumors CMTM3.g 1798 to 2181 384 to 1       384/384
(100 %)
3 diff
(99.3 %id)
AI611065 pooled germ cell tumors CMTM3.g 1799 to 2176 380 to 1       380/380
(100 %)
2 diff
(99.5 %id)
T32911 adrenal gland CMTM3.g 1799 to 2090 1 to 293       293/293
(100 %)
8 diff
(97.3 %id)
AW518815 adenocarcinoma, Pancreas CMTM3.g 1800 to 2172 374 to 1       374/374
(100 %)
7 diff
(98.2 %id)
AW235150 pooled germ cell tumors CMTM3.g 1805 to 2181 381 to 1       381/381
(100 %)
6 diff
(98.5 %id)
W94341 heart CMTM3.g 1809 to 2276 1 to 468   fully sequenced,   468/468
(100 %)
6 diff
(98.8 %id)
AW327573 blood, T cell leukemia CMTM3.g 1811 to 2181 389 to 19   AAA   371/371
(100 %)
0 diff
(100 %id)
FN067531 breast carcinoma CMTM3.g 1814 to 1897 1 to 85       85/85
(100 %)
1 diff
(98.9 %id)
N94375 senescent fibroblast CMTM3.g 1822 to 2329 508 to 2       507/511
(99 %)
0 diff
(100 %id)
AA443656   CMTM3.g 1822 to 2182 365 to 5       361/365
(98 %)
0 diff
(100 %id)
BF941829 fibrotheoma, ovary CMTM3.g 1822 to 2181 360 to 1       360/360
(100 %)
0 diff
(100 %id)
R40646 whole brain CMTM3.g 1823 to 2183 383 to 15   AAA   369/369
(100 %)
10 diff
(97.3 %id)
AA886726 Kidney CMTM3.g 1824 to 2182 359 to 1       359/359
(100 %)
1 diff
(99.8 %id)
AI685615 Prostate CMTM3.g 1824 to 2181 370 to 13   AAA   358/358
(100 %)
1 diff
(99.8 %id)
AA815345   CMTM3.g 1827 to 2162 337 to 2       336/339
(99 %)
0 diff
(100 %id)
AA835539 Spleen CMTM3.g 1827 to 2176 350 to 4       347/352
(98 %)
0 diff
(100 %id)
AI002067 pooled germ cell tumors CMTM3.g 1827 to 2181 355 to 1       355/356
(99 %)
0 diff
(100 %id)
AI492163 B-cell, chronic lymphotic leukemia CMTM3.g 1827 to 2317 509 to 19   AAA   491/491
(100 %)
0 diff
(100 %id)
R85624 liver and spleen CMTM3.g 1829 to 2154 327 to 1       327/327
(100 %)
2 diff
(99.4 %id)
BF934511 nervous_tumor CMTM3.g 1830 to 2185 356 to 1     Submitted on the opposite strand 356/357
(99 %)
1 diff
(99.8 %id)
AI129170 senescent fibroblast CMTM3.g 1831 to 2182 360 to 7       354/360
(98 %)
0 diff
(100 %id)
AW025692 pooled germ cell tumors CMTM3.g 1831 to 2181 353 to 1       353/371
(95 %)
8 diff
(97.9 %id)
BF939332 Prostate CMTM3.g 1833 to 2189 358 to 2       357/358
(99 %)
0 diff
(100 %id)
BQ021434 lung, Metastatic Chondrosarcoma CMTM3.g 1835 to 2181 365 to 19   AAA   347/347
(100 %)
12 diff
(96.6 %id)
AI633828 pooled germ cell tumors CMTM3.g 1840 to 2329 490 to 1   tiling clone,   490/490
(100 %)
2 diff
(99.6 %id)
AI146460 heart CMTM3.g 1841 to 2317 477 to 1       477/477
(100 %)
3 diff
(99.4 %id)
AI955872 adenocarcinoma, Pancreas CMTM3.g 1841 to 2323 484 to 1       484/484
(100 %)
3 diff
(99.4 %id)
BU618779 Cell Line, Chondrosarcoma CMTM3.g 1842 to 2317 495 to 19   AAA   477/477
(100 %)
2 diff
(99.6 %id)
CA429909 Cell Line, Chondrosarcoma CMTM3.g 1849 to 2317 488 to 19   AAA   470/470
(100 %)
1 diff
(99.8 %id)
BP398161 pancreatic islet CMTM3.g 1852 to 2317 1 to 468     Submitted on the opposite strand 468/468
(100 %)
3 diff
(99.4 %id)
AI221619 placenta CMTM3.g 1852 to 2176 325 to 1       325/325
(100 %)
0 diff
(100 %id)
BQ018899 lung, Metastatic Chondrosarcoma CMTM3.g 1853 to 2317 484 to 19   AAA   466/466
(100 %)
1 diff
(99.8 %id)
AI000931 pooled germ cell tumors CMTM3.g 1854 to 2181 328 to 1       328/328
(100 %)
0 diff
(100 %id)
AI127476 heart CMTM3.g 1855 to 2317 474 to 12   AAA   463/463
(100 %)
2 diff
(99.6 %id)
AI186632 placenta CMTM3.g 1855 to 2187 334 to 1       334/334
(100 %)
1 diff
(99.8 %id)
BE466167 carcinoid, lung CMTM3.g 1855 to 2329 477 to 3       475/477
(99 %)
0 diff
(100 %id)
T33895 brain CMTM3.g 1855 to 2323 466 to 1       466/466
(100 %)
10 diff
(97.9 %id)
AW183661 pooled CMTM3.g 1856 to 2182 330 to 4       327/330
(99 %)
0 diff
(100 %id)
AI198123 anaplastic oligodendroglioma, brain CMTM3.g 1858 to 2182 326 to 3       324/327
(99 %)
0 diff
(100 %id)
AA056750 uterus CMTM3.g 1861 to 2176 316 to 1   fully sequenced,   316/316
(100 %)
3 diff
(99.1 %id)
AI342065 pooled germ cell tumors CMTM3.g 1863 to 2318 456 to 1       456/456
(100 %)
1 diff
(99.8 %id)
H15715 whole brain CMTM3.g 1870 to 2118 252 to 1       252/252
(100 %)
4 diff
(98.5 %id)
AI637864 pooled germ cell tumors CMTM3.g 1874 to 2318 445 to 1       445/445
(100 %)
0 diff
(100 %id)
T56923 fetal spleen, Spleen CMTM3.g 1880 to 2318 453 to 4       450/493
(91 %)
0 diff
(100 %id)
BQ004309 Chondrosarcoma, Left Pelvis CMTM3.g 1891 to 2181 309 to 19   AAA   291/291
(100 %)
2 diff
(99.4 %id)
AI634575 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus CMTM3.g 1904 to 2318 415 to 1       415/416
(99 %)
0 diff
(100 %id)
AI289096 serous papillary carcinoma, high grade, 2pooled tumors, uterus CMTM3.g 1905 to 2327 423 to 1       423/423
(100 %)
0 diff
(100 %id)
W94371 heart CMTM3.g 1908 to 2205 299 to 1   fully sequenced,   299/299
(100 %)
0 diff
(100 %id)
AI364856 ovary, tumor, 5 pooled (see description) CMTM3.g 1909 to 2040 132 to 1       132/132
(100 %)
0 diff
(100 %id)
BE645348 Prostate CMTM3.g 1909 to 2183 276 to 2       275/276
(99 %)
0 diff
(100 %id)
Z41816 brain, total brain CMTM3.g 1913 to 2183 271 to 1       271/271
(100 %)
0 diff
(100 %id)
AA486561 lung CMTM3.g 1918 to 2180 264 to 1       264/267
(98 %)
1 diff
(99.7 %id)
AA722755 heart CMTM3.g 1927 to 2318 393 to 2       392/393
(99 %)
0 diff
(100 %id)
AI206504 placenta CMTM3.g 1938 to 2318 381 to 1       381/381
(100 %)
0 diff
(100 %id)
AI801837 Prostate CMTM3.g 1939 to 2317 380 to 1       380/380
(100 %)
2 diff
(99.5 %id)
AI659739 Prostate CMTM3.g 1950 to 2317 369 to 1       369/369
(100 %)
1 diff
(99.8 %id)
AA999697 pooled germ cell tumors CMTM3.g 1952 to 2180 229 to 1       229/229
(100 %)
0 diff
(100 %id)
AI459447 colon CMTM3.g 1952 to 2318 369 to 3       367/369
(99 %)
0 diff
(100 %id)
AI969469 malignant melanoma, metastatic to lymphnode, skin CMTM3.g 1954 to 2317 364 to 1       364/364
(100 %)
0 diff
(100 %id)
AA868142   CMTM3.g 1959 to 2329 372 to 2       371/372
(99 %)
0 diff
(100 %id)
BG055808 anaplastic oligodendroglioma, brain CMTM3.g 1962 to 2318 357 to 1       357/357
(100 %)
0 diff
(100 %id)
BE708514 head_neck CMTM3.g 1964 to 2131 172 to 1       172/209
(82 %)
10 diff
(95.3 %id)
AI699002 adenocarcinoma, Pancreas CMTM3.g 1968 to 2172 209 to 5       205/209
(98 %)
0 diff
(100 %id)
BF446192 Prostate CMTM3.g 1968 to 2177 226 to 17   AAA   210/210
(100 %)
8 diff
(96.2 %id)
AI005381   CMTM3.g 1970 to 2172 209 to 6       204/209
(97 %)
0 diff
(100 %id)
AA609306   CMTM3.g 1971 to 2321 358 to 8       351/358
(98 %)
0 diff
(100 %id)
AW196460 pooled germ cell tumors CMTM3.g 1984 to 2183 200 to 1       200/200
(100 %)
0 diff
(100 %id)
FN098469 breast carcinoma CMTM3.g 1989 to 2098 1 to 109       109/111
(98 %)
5 diff
(95.5 %id)
AI612836 ovary, tumor, 5 pooled (see description) CMTM3.g 1989 to 2181 214 to 22   AAA   193/193
(100 %)
2 diff
(99.0 %id)
AA722994 heart CMTM3.g 1993 to 2182 190 to 1       190/190
(100 %)
0 diff
(100 %id)
BU737297 eye, fetal eyes CMTM3.g 2008 to 2170 1 to 163   AAA Submitted on the opposite strand 163/163
(100 %)
3 diff
(98.2 %id)
BM699562 eye, fetal eyes CMTM3.g 2009 to 2170 179 to 18   AAA Submitted on the opposite strand 162/164
(98 %)
2 diff
(98.8 %id)
AA678759   CMTM3.g 2018 to 2176 159 to 1       159/159
(100 %)
6 diff
(96.3 %id)
BE208337 Kidney, renal cell adenocarcinoma CMTM3.g 2026 to 2329 307 to 4       304/307
(99 %)
0 diff
(100 %id)
AI802221 adenocarcinoma, Pancreas CMTM3.g 2071 to 2318 249 to 2       248/249
(99 %)
0 diff
(100 %id)
T39692 fetal spleen, Spleen CMTM3.g 2087 to 2290 1 to 204       204/204
(100 %)
0 diff
(100 %id)
BE206482 adenocarcinoma cell line, ovary CMTM3.g 2104 to 2183 89 to 10       80/89
(89 %)
0 diff
(100 %id)
AI632619 pooled germ cell tumors CMTM3.g 2132 to 2318 189 to 3       187/189
(98 %)
0 diff
(100 %id)
AA703990 bone marrow stroma CMTM3.g 2138 to 2305 168 to 1       168/168
(100 %)
1 diff
(99.5 %id)
AI203197 pooled germ cell tumors CMTM3.g 2141 to 2317 195 to 19   AAA   177/177
(100 %)
3 diff
(98.4 %id)
AW235727 pooled germ cell tumors CMTM3.g 2147 to 2317 197 to 27   AAA   171/171
(100 %)
4 diff
(97.7 %id)
AI685664 Prostate CMTM3.g 2165 to 2324 163 to 4       160/163
(98 %)
0 diff
(100 %id)
AI597695 Prostate CMTM3.g 2165 to 2324 163 to 4       160/163
(98 %)
0 diff
(100 %id)
AI971096 cochlea, ear, Prostate CMTM3.g 2165 to 2324 163 to 4       160/163
(98 %)
0 diff
(100 %id)
BE673244 Prostate CMTM3.g 2165 to 2324 163 to 4       160/163
(98 %)
0 diff
(100 %id)
BC047701 Brain, fetal, whole pooled CMTM3.h 1 to 1934 1 to 1934 exact tiling clone, available from MGC, AAA   1934/1934
(100 %)
0 diff
(100 %id)
TI_57166093   CMTM3.h 1 to 739 29 to 771 P12L E13R P14A A15C G16R ...     743/772
(96 %)
17 diff
(97.8 %id)
NM_181553.1   CMTM3.h 1 to 1944 1 to 1944 exact RefSeq, AAA   1944/1944
(100 %)
0 diff
(100 %id)
BM928298 brain CMTM3.h 2 to 657 1 to 656       656/1192
(55 %)
5 diff
(99.6 %id)
BI835432 pooled pancreas and spleen CMTM3.h 6 to 739 1 to 738 P12L E13R P14A A15C G16R ...     738/739
(99 %)
19 diff
(97.5 %id)
CR993944 T-Lymphocytes CMTM3.h 6 to 618 1 to 614       614/614
(100 %)
1 diff
(99.9 %id)
DA700167   CMTM3.h 22 to 531 2 to 510   capped   509/510
(99 %)
3 diff
(99.5 %id)
DB039000 testis CMTM3.h 22 to 384 2 to 364   capped   363/363
(100 %)
0 diff
(100 %id)
DB110326 thymus CMTM3.h 22 to 577 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
TI_57171507   CMTM3.h 28 to 821 52 to 862 D7E D11G E13R P14S A15L ...     811/862
(94 %)
32 diff
(96.3 %id)
AL514858 neuroblastoma, placenta CMTM3.h 29 to 956 1 to 927 D5X D91X fully sequenced,   927/927
(100 %)
4 diff
(99.6 %id)
CR611794 Placenta Cot 25-normalized CMTM3.h 33 to 1052 1 to 1020 exact     1020/1020
(100 %)
0 diff
(100 %id)
AL550478 placenta, Placenta Cot 25-normalized CMTM3.h 33 to 996 1 to 957 exact     957/973
(98 %)
16 diff
(98.4 %id)
BX365163 Placenta Cot 25-normalized CMTM3.h 33 to 1043 1 to 1003 I57F     1003/1012
(99 %)
14 diff
(98.7 %id)
BI827612 brain, medulla CMTM3.h 35 to 821 1 to 804 D7E D11G E13R P14S A15L ...     804/804
(100 %)
37 diff
(95.4 %id)
BP206456 coronary artery CMTM3.h 40 to 622 1 to 583       583/583
(100 %)
4 diff
(99.4 %id)
BC036042 testis CMTM3.h 41 to 1798 1 to 1758 exact available from MGC, AAA   1758/1758
(100 %)
1 diff
(100.0 %id)
CB959820 Human Placenta, placenta CMTM3.h 41 to 630 28 to 629       602/758
(79 %)
23 diff
(97.0 %id)
DA981736 synovial membrane tissue from rheumatioidarthritis CMTM3.h 41 to 290 2 to 251   capped   250/250
(100 %)
1 diff
(99.6 %id)
DB251306 uterus CMTM3.h 41 to 604 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA008007   CMTM3.h 42 to 332 2 to 292   capped   291/291
(100 %)
1 diff
(99.7 %id)
DA260685 caudate nucleus CMTM3.h 42 to 285 2 to 245   capped   244/244
(100 %)
1 diff
(99.6 %id)
DA462764   CMTM3.h 42 to 527 2 to 487   capped   486/486
(100 %)
0 diff
(100 %id)
DA541419 lung CMTM3.h 42 to 628 2 to 588   capped   587/587
(100 %)
2 diff
(99.7 %id)
DA699813   CMTM3.h 42 to 504 2 to 464   capped   463/463
(100 %)
1 diff
(99.8 %id)
DA737268   CMTM3.h 42 to 784 2 to 747 K156N F157S L158S K159N Q160K ... capped   746/747
(99 %)
9 diff
(98.8 %id)
DA834948 placenta CMTM3.h 42 to 505 2 to 465   capped   464/464
(100 %)
0 diff
(100 %id)
DA850156 placenta CMTM3.h 42 to 270 2 to 230   capped   229/229
(100 %)
0 diff
(100 %id)
DA879182 Prostate CMTM3.h 42 to 450 2 to 410   capped   409/409
(100 %)
0 diff
(100 %id)
DA963648 stomach CMTM3.h 42 to 600 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DA981754 synovial membrane tissue from rheumatioidarthritis CMTM3.h 42 to 613 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DB036006 testis CMTM3.h 42 to 379 2 to 339   capped   338/338
(100 %)
2 diff
(99.5 %id)
DB037961 testis CMTM3.h 42 to 504 2 to 464   capped   463/463
(100 %)
0 diff
(100 %id)
DB189816 lung, tumor tissue CMTM3.h 42 to 609 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA004919   CMTM3.h 43 to 329 2 to 288   capped   287/287
(100 %)
1 diff
(99.7 %id)
BC040227 Colon, Kidney, Stomach, adult, whole pooled CMTM3.h 50 to 1800 1 to 1751 exact available from MGC, AAA   1751/1751
(100 %)
0 diff
(100 %id)
CN403992 embryonic stem cells, cell lines H1, H7, andH9 CMTM3.h 52 to 517 56 to 521       466/521
(89 %)
6 diff
(98.9 %id)
CF593713 Human Placenta, placenta CMTM3.h 53 to 722 25 to 702 N152K D153R V154R A155G K156Q ...     678/857
(79 %)
29 diff
(96.7 %id)
BX353643 Neuroblastoma Cot 25-normalized CMTM3.h 57 to 716 1 to 660 P3X I57X     660/660
(100 %)
0 diff
(100 %id)
CR999233 T-Lymphocytes CMTM3.h 60 to 542 1 to 484       484/500
(96 %)
2 diff
(99.6 %id)
CR621105 Neuroblastoma Cot 25-normalized CMTM3.h 61 to 1777 1 to 1717 exact     1717/1717
(100 %)
0 diff
(100 %id)
AL526558 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized CMTM3.h 61 to 939 1 to 870 W2X P3X D5X P6X fully sequenced,   870/870
(100 %)
1 diff
(99.9 %id)
AL526504 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized CMTM3.h 909 to 1777 860 to 1   fully sequenced,   860/860
(100 %)
6 diff
(99.4 %id)
AL514857 neuroblastoma, placenta CMTM3.h 926 to 1789 860 to 1   fully sequenced,   860/860
(100 %)
34 diff
(96.1 %id)
BX350977 Neuroblastoma Cot 25-normalized CMTM3.h 1210 to 1772 600 to 28       573/652
(87 %)
0 diff
(100 %id)
DB328715 placenta CMTM3.h 1580 to 1798 219 to 1       219/219
(100 %)
0 diff
(100 %id)
BI161009 epithelioid carcinoma cell line, Pancreas CMTM3.i 1 to 844 1 to 837 Q7K E8K E10R R11G A12H ... tiling clone,   837/837
(100 %)
21 diff
(97.5 %id)
BI457147 epithelioid carcinoma cell line, Pancreas CMTM3.i 1 to 962 1 to 957 exact tiling clone,   957/961
(99 %)
44 diff
(95.5 %id)
TI_45133387   CMTM3.i 2 to 962 60 to 1015       956/960
(99 %)
43 diff
(95.6 %id)
BI762794 pooled colon, kidney, stomach CMTM3.i 134 to 318 191 to 376       321/376
(85 %)
29 diff
(92.3 %id)
DA045077 bladder CMTM3.j 1 to 459 2 to 460   tiling clone, capped   459/459
(100 %)
1 diff
(99.8 %id)
CT001840 T-Lymphocytes CMTM3.j 46 to 872 1 to 828 exact     828/828
(100 %)
2 diff
(99.8 %id)
AL557248 T cells (Jurkat cell line), T cells from T cell leukemia CMTM3.j 48 to 1010 1 to 942 D9N A153V A155Q A156Q A157P ... fully sequenced, AAA   942/942
(100 %)
24 diff
(97.5 %id)
AL557097 T cells (Jurkat cell line), T cells from T cell leukemia CMTM3.j 53 to 1014 1 to 952 P3X D9N A153V A155Q A156Q ... fully sequenced, AAA   952/952
(100 %)
9 diff
(99.1 %id)
CR608574 T cells (Jurkat cell line) CMTM3.j 55 to 1995 1 to 1941 exact tiling clone,   1941/1941
(100 %)
0 diff
(100 %id)
BU150300 dorsal root ganglia CMTM3.j 121 to 945 1 to 833       833/931
(89 %)
14 diff
(98.5 %id)
AL579323 T cells (Jurkat cell line), T cells from T cell leukemia CMTM3.j 980 to 1703 715 to 1   fully sequenced,   715/715
(100 %)
58 diff
(91.9 %id)
AL579200 T cells (Jurkat cell line), T cells from T cell leukemia CMTM3.j 984 to 1995 1002 to 1   fully sequenced,   1002/1002
(100 %)
22 diff
(97.9 %id)
BQ920574 carcinoma, cell line, Prostate CMTM3.k 1 to 739 1 to 755 K139Q tiling clone,   755/989
(76 %)
24 diff
(97.6 %id)
BG761479 melanotic melanoma, high MDR (cell line), skin CMTM3.k 3 to 753 1 to 758 E74A F75V L76P L77A A78G ... tiling clone,   758/760
(99 %)
10 diff
(98.7 %id)
BG766427 melanotic melanoma, high MDR (cell line), skin CMTM3.k 3 to 777 1 to 796 W2V P3A D5M P6T D7P ... tiling clone,   796/797
(99 %)
37 diff
(95.4 %id)
BQ929037 carcinoma, cell line, Prostate CMTM3.k 3 to 471 1 to 468       468/1023
(45 %)
14 diff
(98.7 %id)
BF356033 head_neck CMTM3.l-u 1 to 402 1 to 400 G2V L5T H7M D8M G9V ... tiling clone,   400/402
(99 %)
14 diff
(96.6 %id)
BM555793 duodenal adenocarcinoma, cell line, small intestine CMTM3.m-u 1 to 903 1 to 912   tiling clone,   912/1012
(90 %)
21 diff
(98.0 %id)
EB385711 eye, optic nerve CMTM3.m-u 856 to 1686 1 to 831   tiling clone,   831/831
(100 %)
0 diff
(100 %id)
BX340224 Placenta Cot 25-normalized CMTM3.n 1 to 1122 1 to 1113 L18S S19L Q21R D22T F23S ... tiling clone,   1113/1118
(99 %)
15 diff
(98.7 %id)
BG118168 adenocarcinoma, cell line, Liver CMTM3.o 1 to 711 1 to 710 I35S A36P K37S Y38T S39R ... tiling clone,   710/927
(76 %)
19 diff
(98.0 %id)
AY166714 Liver CMTM3.p 1 to 657 1 to 650 exact tiling clone,   650/666
(97 %)
13 diff
(98.1 %id)
CN403987 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells Gene CMTM3, variant not shown         Suspected internal deletion, this clone was ignored    
BU164004 embryonal carcinoma, cell line, testis Gene CMTM3, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l-u, .m-u, .n, .o, .p Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI